Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,536.08
(
-1.07%
)
US TECH 100
23,348.20
(
-1.57%
)
Dow Jones
45,750.46
(
-0.59%
)
Brent Oil
107.36
(
2.80%
)
Bitcoin
69,693.01
(
-0.29%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 83882

Tuesday, 09/22/2009 10:05:30 AM

Tuesday, September 22, 2009 10:05:30 AM

Post# of 257262
AMGN’s D-mab in BC trial - more data:
The median time to first on-study SRE was not reached for denosumab (meaning it is >34 months) and was 26.5 months for Zometa.

http://wwwext.amgen.com/media/media_pr_detail.jsp?year=2009&releaseID=1334123
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now